AGN - AbbVie Still Yields Over 5%

AbbVie (ABBV) has seen a sharp rally in the stock following the large dip over the Summer, after announcing the debt-fueled deal to acquire Allergan (AGN). At the current price of $87, the stock still yields an incredible 5.4% for yield-starved investors. The key to AbbVie is not paying attention to where the stock came from, with the focus on where the stock is going in 2020 with the EPS boost from Allergan and a strong drug pipeline to offset the patent loss exclusivity on Humira. My investment thesis remains very

Read more ...